Pasar al contenido principal

BIOMARCADORES CENTRALES Y PERIFERICOS DE RESPUESTA ANTIDEPRESIVA: ESTUDIO TRANSLACIONAL ENTRE PACIENTES CON TRASTORNO DEPRESIVO RESITENTE AL TRATAMIENTO Y MODELO DE DEPRESION EN RATA

PI18/00036

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARC TAULI
Centro realización CORPORACION SANITARIA PARC TAULI

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

The neurobiological basis of cognitive side effects of electroconvulsive therapy, a systematic review

  • Bassa, Adriana
  • Sagués, Teresa
  • Porta-Casteràs, Daniel|||0000-0002-3921-3607
  • Serra, Pilar
  • Martínez Amorós, Erika|||0000-0002-6718-7346
  • Palao, Diego|||0000-0002-3323-6568
  • Cano, Marta|||0000-0003-0675-9483
  • Cardoner, Narcís|||0000-0001-9633-0888
Decades of research have consistently demonstrated the efficacy of electroconvulsive therapy (ECT) for the treatment of major depressive disorder (MDD), but its clinical use remains somewhat restricted because of its cognitive side effects. The aim of this systematic review is to comprehensively summarize current evidence assessing potential biomarkers of ECT-related cognitive side effects. Based on our systematic search of human studies indexed in PubMed, Scopus, and Web of Knowledge, a total of 29 studies evaluating patients with MDD undergoing ECT were reviewed. Molecular biomarkers studies did not consistently identify concentration changes in plasma S-100 protein, neuron-specific enolase (NSE), or Aβ peptides significantly associated with cognitive performance after ECT. Importantly, these findings suggest that ECT-related cognitive side effects cannot be explained by mechanisms of neural cell damage. Notwithstanding, S-100b protein and Aβ40 peptide concentrations, as well as brain-derived neurotrophic factor (BDNF) polymorphisms, have been suggested as potential predictive biomarkers of cognitive dysfunction after ECT. In addition, recent advances in brain imaging have allowed us to identify ECT-induced volumetric and functional changes in several brain structures closely related to memory performance such as the hippocampus. We provide a preliminary framework to further evaluate neurobiological cognitive vulnerability profiles of patients with MDD treated with ECT.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders

  • Segal, Ashlea|||0000-0002-7451-6195
  • Parkes, Linden|||0000-0002-9329-7207
  • Aquino, Kevin
  • Kia, Seyed Mostafa
  • Wolfers, Thomas
  • Franke, Barbara|||0000-0003-4375-6572
  • Hoogman, Martine|||0000-0002-1261-7628
  • Beckmann, Christian F.
  • Westlye, Lars T.|||0000-0001-8644-956X
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Zalesky, Andrew|||0000-0003-2298-9908
  • Harrison, Ben J.
  • Davey, Christopher|||0000-0003-1431-3852
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Tiego, Jeggan|||0000-0001-7835-6398
  • Yücel, Murat|||0000-0002-4705-452X
  • Braganza, Leah
  • Suo, Chao
  • Berk, Michael
  • Cotton, Sue
  • Bellgrove, Mark A.|||0000-0003-0186-8349
  • Marquand, Andre F.|||0000-0001-5903-203X
  • Fornito, Alex|||0000-0003-0866-3477
The substantial individual heterogeneity that characterizes people with mental illness is often ignored by classical case-control research, which relies on group mean comparisons. Here we present a comprehensive, multiscale characterization of the heterogeneity of gray matter volume (GMV) differences in 1,294 cases diagnosed with one of six conditions (attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, depression, obsessive-compulsive disorder and schizophrenia) and 1,465 matched controls. Normative models indicated that person-specific deviations from population expectations for regional GMV were highly heterogeneous, affecting the same area in <7% of people with the same diagnosis. However, these deviations were embedded within common functional circuits and networks in up to 56% of cases. The salience-ventral attention system was implicated transdiagnostically, with other systems selectively involved in depression, bipolar disorder, schizophrenia and attention-deficit/hyperactivity disorder. Phenotypic differences between cases assigned the same diagnosis may thus arise from the heterogeneous localization of specific regional deviations, whereas phenotypic similarities may be attributable to the dysfunction of common functional circuits and networks. A new brain mapping approach tailored to individual people reveals that volume changes in psychiatric illness occur in highly variable locations across individuals, but that these differences often aggregate within common brain systems.